DAX22.272 +0,1%ESt505.170 +0,3%Top 10 Crypto12,13 -3,7%Dow40.228 +0,3%Nas17.366 -0,1%Bitcoin83.395 +0,1%Euro1,1408 -0,1%Öl65,63 ±-0,0%Gold3.332 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Rheinmetall 703000 Tesla A1CX3T RENK RENK73 BYD A0M4W9 Lufthansa 823212 BASF BASF11 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Telekom 555750 Siemens Energy ENER6Y Allianz 840400 Volkswagen (VW) vz. 766403 Amazon 906866 Bayer BAY001 Novo Nordisk A3EU6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt im Plus -- US-Börsen schließen uneinheitlich -- Akzo Nobel hat wohl Interesse an BASF-Lacke-Geschäft -- Merck: SpringWorks-Übernahme gesichert -- D-Wave Quantum, NVIDIA, Ripple im Fokus
Top News
Wall Street-Anleger vor Bilanzflut vorsichtig: Dow und NASDAQ schließen uneinheitlich Wall Street-Anleger vor Bilanzflut vorsichtig: Dow und NASDAQ schließen uneinheitlich
Porsche-Aktie unter Druck: VW-Tochter Porsche senkt Prognose - US-Zölle und Mehrkosten für Batterien Porsche-Aktie unter Druck: VW-Tochter Porsche senkt Prognose - US-Zölle und Mehrkosten für Batterien
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Europäische Aktien bieten Grund für Optimismus. Ihre Aussichten könnten langfristig besser sein als für die erfolgsverwöhnten US-Titel. DWS informiert

Abbott Laboratories Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
114,58 EUR +1,02 EUR +0,90 %
FSE
129,75 USD +0,20 USD +0,15 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.195,77 Mrd. EUR

KGV14,81Div. Rendite1,98%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN850103

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS0028241000

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolABT

Abbott Laboratories Aktien News

DatumMeistgelesen
PR NewswireAbbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
PR NewswireNew Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
PR NewswireNew Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
Wer­bungAbbott Laboratories-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireAbbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
PR NewswireNew Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart Valve
PR NewswireAbbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
PR NewswireAbbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
PR NewswireAbbott Hosts Conference Call for First-Quarter Earnings
PR NewswireAbbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease
PR NewswireAbbott Declares 405th Consecutive Quarterly Dividend
PR NewswireAbbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
PR NewswireAbbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
PR NewswireAbbott Hosts Conference Call for Fourth-Quarter Earnings
PR NewswireAbbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta
PR NewswireAbbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
PR NewswireAbbott Increases Quarterly Dividend for 53rd Consecutive Year
PR NewswireUniversity of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant from Abbott
PR NewswireAbbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
PR NewswireAbbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland
PR NewswireAbbott eröffnet eine hochmoderne globale Produktionsstätte in Kilkenny, Irland
PR NewswireNew Canadian Report Shows Positivity Instead of Criticism is Key in Diabetes Management
PR NewswireAbbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure
PR NewswireAbbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping
PR NewswireAbbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'
PR NewswireAbbott Hosts Conference Call for Third-Quarter Earnings
PR NewswireAbbott Declares 403rd Consecutive Quarterly Dividend
PR NewswireAbbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.
PR NewswireAbbott Initiates Clinical Study to Evaluate the Use of Its Deep Brain Stimulation System to Manage Severe Depression
PR NewswireAbbott Expands its Pure Bliss™ Line of Infant Formulas to Include European-Made and Organic Products; Offers the First and Only Organic Liquid Formula Available at U.S. Retail Stores
PR NewswireAbbott's AVEIR™ DR - World's First Dual Chamber Leadless Pacemaker System - Now Available in Canada
PR NewswireQuebec Expands Public Reimbursement of Abbott's FreeStyle Libre® 2 Flash Glucose Monitoring System to More Adults with Diabetes
PR NewswireAbbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
PR NewswireAbbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
PR NewswireCadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs
PR NewswireAbbott Hosts Conference Call for Second-Quarter Earnings
PR NewswireAbbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
PR NewswireAbbott Declares 402nd Consecutive Quarterly Dividend
PR NewswireAbbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
PR NewswireCadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Wer­bung

Abbott Laboratories News

Abbott Laboratories News: auf dieser Seite finden Sie alle Abbott Laboratories News und Nachrichten zur Abbott Laboratories Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Abbott Laboratories News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Abbott Laboratories News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.